The MTHFR C677T Polymorphism and Hyperuricemia Risk: A Meta-Analysis of 558 Cases and 912 Controls

Journal of Postgenomics Drug & Biomarker Development
doi 10.4172/2153-0769.1000166
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

MTHFR C677T Polymorphism and Breast, Ovarian Cancer Risk: A Meta-Analysis of 19,260 Patients and 26,364 Controls

OncoTargets and Therapy
OncologyPharmacology
2017English

Association Between the MTHFR C677T Polymorphism and Gastric Cancer Susceptibility: A Meta-Analysis of 5,757 Cases and 8,501 Controls

Oncology Letters
Cancer ResearchOncology
2015English

Maternal MTHFR C677T Polymorphism and Congenital Heart Defect Risk in the Chinese Han Population: A Meta-Analysis

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2013English

Association of the MTHFR C677T Polymorphism and Bone Mineral Density in Postmenopausal Women: A Meta-Analysis

Journal of Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
2010English

The MTHFR C677T Polymorphism and Risk of Intracerebral Hemorrhage in a Chinese Han Population

Medical Science Monitor
Medicine
2016English

MTHFR C677T Polymorphism and Thyroid Cancer Risk in Duhok, Kurdistan Region –Iraq

ZANCO JOURNAL OF PURE AND APPLIED SCIENCES
2018English

MTHFR C677T Polymorphism Is Associated With Methotrexate-Induced Myelopathy Risk

Neurology
Neurology
2017English

Significant Association Between the MTHFR A1298C Polymorphism and Hepatocellular Carcinoma Risk: A Meta-Analysis

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

Methylenetetrahydrofolate Reductase C677T Polymorphism and Colorectal Cancer Susceptibility: A Meta-Analysis

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy